The Centers for Disease Control and Prevention declared racism a “serious public health threat” that “affects the health of our entire nation.” The agency has created a new section on its website focused solely on racism and health. (Politico)

Low vaccination rates have persisted in certain states. In Mississippi, only a quarter of residents have received one dose, in comparison to 33% nationwide. (The New York Times)

As part of a push to develop therapies for cancer and immunological disorders, Sanofi has acquired mRNA biotech Tidal Therapeutics. Sanofi bought the company for $160 million in cash. (Endpoints News)

New COVID-19 variants will define the next phase of the pandemic, experts said. They believe vaccinations will be the only way to curb new variants from emerging. (The Washington Post)

A new immunotherapy harnessing natural “killer” cells showed promising results in treating advanced Hodgkin’s lymphoma, according to a new study. The therapy is being developed by German immuno-oncology company Affimed. (STAT)